Inspectors of Marck Biosciences found an array of problems during a October-November 2013 inspection, including mold near a sterile area that was so bad “the room had ‘partially caved in.'”
Generic Viagra floods Brazil
August 12, 2014
4:02 pm
The generic ED pills sell for five cents less than Pfizer’s branded blue pill, but the undercutting is a bit deeper.
India establishes inspection guidelines
August 12, 2014
4:00 pm
The new rules are expected to do away with the haphazard nature of facility inspections.
China lifts some pricing restrictions
May 8, 2014
3:40 pm
Drug quality problems and shortages are behind the shift that will affect antibiotics, painkillers and vitamins.
Gilead ponders Sovaldi price break
February 4, 2014
6:20 pm
The drug maker is reportedly talking low rates for India’s market.
Actavis wants out of China
January 16, 2014
5:58 pm
The generics drugmaker tells Bloomberg the hassle is not worth it.
The company releases 2014 guidance Tuesday, but signals from the previous 12 months indicate the Indiana drugmaker is determined to hit its $20-billion earnings target, patent losses be damned.
Takeda’s sales-op expansion continues
December 18, 2013
5:03 pm
The Japanese drugmaker’s Israeli operation marks its sixth new sales outpost this year.
The catch is the difference between sales and revenues. Generics will continue to be a force, and small-audience drugs will become increasingly important.
India’s dual pricing pressures
November 14, 2013
5:37 pm
Domestic manufacturers are being pressured to offer domestic discounts to international clients.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix